Search

Author/Creator Suleiman, Ahmed A.

3. Industrial Perspective on the Benefits Realized From the FDA's Model‐Informed Drug Development Paired Meeting Pilot Program. Issue 5 (15th May 2021)

Authors:
Galluppi, Gerald R.; Brar, Satjit; Caro, Luzelena; Chen, Yuan; Frey, Nicolas; Grimm, Hans Peter; Rudd, Deanne Jackson; Li, Chi‐Chung; Magee, Mindy; Mukherjee, Arnab; Nagao, Lee; Purohit, Vivek S.; Roy, Amit; Salem, Ahmed Hamed; Sinha, Vikram; Suleiman, Ahmed A.; Taskar, Kunal S.; Upreti, Vijay V....
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 110:Issue 5(2021)
Page Start:
1172
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment. (21st May 2020)

Authors:
Nogova, Lucia; Mattonet, Christian; Scheffler, Matthias; Taubert, Max; Gardizi, Masyar; Sos, Martin L.; Michels, Sebastian; Fischer, Rieke N.; Limburg, Meike; Abdulla, Diana S.Y.; Persigehl, Thorsten; Kobe, Carsten; Merkelbach‐Bruse, Sabine; Franklin, Jeremy; Backes, Heiko; Schnell, Roland; Behri...
Journal:
Cancer medicine
Issue:
Volume 9:Number 14(2020)
Page Start:
4991
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis. Issue 4 (7th May 2021)

Authors:
Stodtmann, Sven; Nader, Ahmed; Polepally, Akshanth R.; Suleiman, Ahmed A.; Winzenborg, Insa; Noertersheuser, Peter; Ng, Juki; Mostafa, Nael M.; Shebley, Mohamad
Journal:
Clinical and translational science
Issue:
Volume 14:Issue 4(2021)
Page Start:
1611
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗